Upcoming Event: 2nd Annual China Biopharma Opportunities Summit 2009
2/13/2009
Event: 2nd Annual China Biopharma Opportunities Summit 2009 - Protein
and Gene Pharmaceuticals: Innovation Industrialization
Date: April 22-24, 2009
Place: Shanghai, China
Contact: tina@igvision.com
Weblink: www.biochinaforum.com
2nd Annual China Biopharma Opportunities Summit will be held on April 22nd – 24th, 2009 in Shanghai, China. This summit is hosted by Shanghai Society for Biotechnology (SSBT), and endorsored by EU Biovalley, The Development Center for Biotechnology of Taiwan (DCB) , Shanghai Biochip Co.Ltd, Japan Bioindustry Association (JBA), Shanghai Zhangjiang Hi-Tech Park and other famous institutes and associations.
Characterized by Gene Engineering, Cell Engineering, Enzymatic Engineering and Zymolysis Engineering, biotechnology develops at a rapid pace. Meanwhile, Biopharmaceuticals, as an active industry in the development and utilization of bioengineering, becomes as serious as electronics, new materials and areanotics do. The inventions of stem cells, biochip and other techniques bring innovation of biophamaceutical, and bring high attentions from goverments, worldwide industries and investors. At present, large-scale biotechnology companies and parmaceuticals are enlarging its business to pharma industry, in order to maximize its market and find best research partner all of the world. On the other hand, investors are looking for opportunities by sharing updated dates and information of new technologies. From a global perspective, the concentrated areas in the research and development of pharma will be vaccine, humanized monoclonal antibody, gene treatment and interferon.
2nd Annual China Biopharma Opportunities Summit mainly concerns the latest biopharmas and biologics innovations and industrialization issues. It provides an opportunity of multilateral and face-to-face interaction for biopharma community members – research institutes, biopharma corporations, and financial & investing institutions, etc. Upon the establishment and improvement of the China Drug Supervision and Administration System, the global biopharma industry value chain has been shifting forwards the biotech industry zones in China. The issues on independnet biopharma innovetions and sustainable industrialization in China will be futher discussed in this summit.
The main topics covered in this summit are followings:
· The latest innovations on protein & gene pharmaceuticals
· Biopharma industry value chain management, the upcoming industrialization model, industry expansion vs. capital expansion, and IP right protection, etc.
· In-depth review: the impact from bioinformatics, drug licensing and alliance management in China, and CRO market for diagnostic services.
· Generic pharma market trend in China: the expansion of domestic demand and venturing the oversea market.
· Showcase: biopharma technologies & intermediates, and laboratory technology and software support.
· Workshop: global attention on biochip
· Site Tour: face-to-face multilateral communication
This summit will invite renowned elites from world famous institutes and companies---Genentech, Cogenics, Science & Tecnology Commision of Shanghai Municipal, GE Healthcare, Shanghai Insititute of Pharmaceutical Industry, Biovalley, CapitalBio Corporation, Biogen Idec, The Development Center for Biotechnology of Taiwan, Shanghai Insititute for Biological Sciences, Merck & Co.In, Pfizer, and Eli Lily and Company.
For more information, please contact:
tina@igvision.com;